Log inSign up
Isomorphic Labs
290 posts
Image
user avatar
Isomorphic Labs
@IsomorphicLabs
Solve all disease. Developing and applying frontier AI to unlock deeper scientific insights, faster breakthroughs, and life-changing medicines.
isomorphiclabs.com
Joined January 2021
82
Following
57.8K
Followers
  • Pinned
    user avatar
    Isomorphic Labs
    @IsomorphicLabs
    May 12
    Today marks a pivotal moment for Isomorphic Labs. We have secured $2.1 Billion in our second external funding round, led by Thrive Capital. They are joined at the table by Alphabet, GV and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund. This milestone
    Image
    00:00
    273K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    May 8, 2024
    We're excited to announce #AlphaFold 3 with @GoogleDeepMind in @Nature: our new AI model for predicting biomolecule structures with unprecedented breadth and accuracy. Expanding beyond proteins to tackle DNA, RNA, small molecules to fuel advances in biology & drug design 🧵
    Image
    00:00
    297K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Oct 9, 2024
    We are thrilled to share the breaking news that our CEO and founder @demishassabis and @GoogleDeepMind colleague John Jumper have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking work creating AlphaFold alongside David Baker for computational protein
    Image
    61K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Sep 12, 2025
    Our CEO @demishassabis, Chief AI Officer @maxjaderberg, and Head of Medicinal Drug Design @_rebecca_paul were featured on the latest episode of Bloomberg Tech Europe (@technology) to share how we're leveraging frontier AI in groundbreaking ways to reimagine drug discovery and
    Image
    Watch How AI Company Isomorphic Labs Is Working to Solve All Disease | Bloomberg Tech: Europe...
    From bloomberg.com
    65K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    May 8, 2024
    How could #AlphaFold 3 transform drug discovery? Most drugs are small molecules known as ligands that bind to proteins to change how they interact in human health and disease. AlphaFold 3 can predict these interactions to atomic accuracy.
    Image
    00:00
    75K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    May 8, 2025
    One year ago today, we published the breakthrough AI model #AlphaFold 3 together with @GoogleDeepMind. AlphaFold 3 allows researchers to model the structures and interactions of all of life’s molecules with unprecedented accuracy. With the ability to model proteins, DNA, RNA, and
    Image
    23K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Jan 7, 2024
    We are thrilled to announce our pharma collaborations with @EliLillyandCo & @Novartis, which combined are potentially worth nearly $3 billion and testament to the promise of our AI-first approach to drug design. Read more here: bit.ly/3TUIaB5 #AI #drugdiscovery
    Isomorphic Labs logo in the centre of a formation of pink and orange cubes that characterise the branding.
    124K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Oct 31, 2023
    Today in partnership with @GoogleDeepMind we're sharing progress on the next generation of #AlphaFold Our new model greatly expands coverage of structure prediction beyond proteins to other biomolecular classes. Here's how it could advance drug design: bit.ly/45Qt4yT 🧵
    Image
    00:00
    60K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Feb 18, 2025
    We are excited to announce the expansion of our collaboration with @Novartis, doubling the number of research programs just over a year after initiating our partnership. This expansion is testament to the great progress we’ve made together and further unlocks the potential to
    Isomorphic Labs announces Novartis collaboration expansion
    50K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Mar 31, 2025
    @IsomorphicLabs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. We are thrilled to announce $600 million of investment raised in a round led by @ThriveCapital with
    Image
    74K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Jun 17, 2025
    We're excited to welcome Dr. Ben Wolf, M.D., Ph.D., as our new Chief Medical Officer at Isomorphic Labs! Dr. Wolf brings nearly 20 years of biopharmaceutical experience to the team, and will be based in our new Cambridge, Massachusetts location as we advance therapeutic programs
    Image
    37K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    May 9, 2024
    With AlphaFold 3 we can now create and test hypotheses at the atomic level, and produce highly accurate structure predictions within seconds. Find out how we got here and how we’re using it to transform drug discovery:
    Image
    Rational drug design with AlphaFold 3 - Isomorphic Labs
    From isomorphiclabs.com
    16K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Jul 9, 2025
    We are thrilled to welcome Sarah Skerratt as our new Chief Research Officer! Her extensive medicinal chemistry and drug discovery expertise across multiple target classes will be instrumental in advancing our pipeline towards the clinic.
    Image
    28K
  • user avatar
    Isomorphic Labs
    @IsomorphicLabs
    Apr 16, 2024
    Many congratulations to our CEO @demishassabis and colleague John Jumper at @GoogleDeepMind, who were honoured this weekend with a Breakthrough Prize in Life Sciences for their work on AlphaFold. Read more here: bit.ly/3UhPlmO #AI #machinelearning
    Isomorphic Labs' CEO Demis Hassabis is standing with John Jumper from Google DeepMind. Both are wearing formal clothing and are smiling at the camera whilst holding their Breakthrough Awards for Life Sciences.
    11K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up